Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Erratum to: Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease, Ectopic Pregnancy, and Female Infertility: A Retrospective Cohort Study Among Primary Care Patients.

Den Heijer CDJ, Hoebe CJPA, Driessen JHM, Wolffs P, Van Den Broek IVF, Hoenderboom BM, Williams R, De Vries F, Dukers-Muijrers NHTM.

Clin Infect Dis. 2019 Sep 19. pii: ciz897. doi: 10.1093/cid/ciz897. [Epub ahead of print] No abstract available.

PMID:
31535123
2.

Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease, Ectopic Pregnancy, and Female Infertility: A Retrospective Cohort Study Among Primary Care Patients.

den Heijer CDJ, Hoebe CJPA, Driessen JHM, Wolffs P, van den Broek IVF, Hoenderboom BM, Williams R, de Vries F, Dukers-Muijrers NHTM.

Clin Infect Dis. 2019 Aug 24. pii: ciz429. doi: 10.1093/cid/ciz429. [Epub ahead of print]

PMID:
31504315
3.

Relation between Chlamydia trachomatis infection and pelvic inflammatory disease, ectopic pregnancy and tubal factor infertility in a Dutch cohort of women previously tested for chlamydia in a chlamydia screening trial.

Hoenderboom BM, van Benthem BHB, van Bergen JEAM, Dukers-Muijrers NHTM, Götz HM, Hoebe CJPA, Hogewoning AA, Land JA, van der Sande MAB, Morré SA, van den Broek IVF.

Sex Transm Infect. 2019 Jun;95(4):300-306. doi: 10.1136/sextrans-2018-053778. Epub 2019 Jan 3.

4.

National prevalence estimates of chlamydia and gonorrhoea in the Netherlands.

Heijne JCM, van den Broek IVF, Bruisten SM, van Bergen JEA, de Graaf H, van Benthem BHB.

Sex Transm Infect. 2019 Feb;95(1):53-59. doi: 10.1136/sextrans-2017-053478. Epub 2018 Jun 20.

PMID:
29925670
5.

A pill for the partner via the chlamydia patient? Results from a mixed method study among sexual health care providers in the Netherlands.

Nanhoe AC, Visser M, Omlo JJ, Watzeels AJCM, van den Broek IV, Götz HM.

BMC Infect Dis. 2018 May 29;18(1):243. doi: 10.1186/s12879-018-3139-0.

6.

STIs in sex partners notified for chlamydia exposure: implications for expedited partner therapy.

van Aar F, van Benthem BHB, van den Broek IVF, Götz HM.

Sex Transm Infect. 2018 Dec;94(8):619-621. doi: 10.1136/sextrans-2017-053364. Epub 2018 Jan 11.

PMID:
29326177
7.

Partner notification and partner treatment for chlamydia: attitude and practice of general practitioners in the Netherlands; a landscape analysis.

van den Broek IVF, Donker GA, Hek K, van Bergen JEAM, van Benthem BHB, Götz HM.

BMC Fam Pract. 2017 Dec 20;18(1):103. doi: 10.1186/s12875-017-0676-3.

8.

Chlamydia trachomatis antibody detection in home-collected blood samples for use in epidemiological studies.

Hoenderboom BM, van Ess EF, van den Broek IVF, van Loo IHM, Hoebe CJPA, Ouburg S, Morré SA.

J Microbiol Methods. 2018 Jan;144:164-167. doi: 10.1016/j.mimet.2017.11.022. Epub 2017 Nov 28.

9.

The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women.

Hoenderboom BM, van Oeffelen AA, van Benthem BH, van Bergen JE, Dukers-Muijrers NH, Götz HM, Hoebe CJ, Hogewoning AA, van der Klis FR, van Baarle D, Land JA, van der Sande MA, van Veen MG, de Vries F, Morré SA, van den Broek IV.

BMC Infect Dis. 2017 Apr 11;17(1):264. doi: 10.1186/s12879-017-2376-y.

10.

The need to scale up HIV indicator condition-guided testing for early case-finding: a case-control study in primary care.

Joore IK, Twisk DE, Vanrolleghem AM, de Ridder M, Geerlings SE, van Bergen JE, van den Broek IV.

BMC Fam Pract. 2016 Nov 17;17(1):161.

11.

Ethnic and regional differences in STI clinic use: a Dutch epidemiological study using aggregated STI clinic data combined with population numbers.

van Oeffelen AA, van den Broek IV, Doesburg M, Boogmans B, Götz HM, van Leeuwen-Voerman FA, van Veen MG, Woestenberg PJ, van Benthem BH, van Steenbergen JE.

Sex Transm Infect. 2017 Feb;93(1):46-51. doi: 10.1136/sextrans-2016-052558. Epub 2016 Jun 28.

PMID:
27606682
12.

Missed opportunities to offer HIV tests to high-risk groups during general practitioners' STI-related consultations: an observational study.

Joore IK, Reukers DF, Donker GA, van Sighem AI, Op de Coul EL, Prins JM, Geerlings SE, Barth RE, van Bergen JE, van den Broek IV.

BMJ Open. 2016 Jan 21;6(1):e009194. doi: 10.1136/bmjopen-2015-009194.

13.

Changes in chlamydia control activities in Europe between 2007 and 2012: a cross-national survey.

van den Broek IV, Sfetcu O, van der Sande MA, Andersen B, Herrmann B, Ward H, Götz HM, Uusküla A, Woodhall SC, Redmond SM, Amato-Gauci AJ, Low N, van Bergen JE.

Eur J Public Health. 2016 Jun;26(3):382-8. doi: 10.1093/eurpub/ckv196. Epub 2015 Oct 24.

14.

Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection.

Vriend HJ, Bogaards JA, van Bergen JE, Brink AA, van den Broek IV, Hoebe CJ, King AJ, van der Sande MA, Wolffs PF, de Melker HE; Medical Microbiological Laboratories and the CSI group.

Cancer Med. 2015 Oct;4(10):1589-98. doi: 10.1002/cam4.496. Epub 2015 Jul 21.

15.

Comparison of STI-related consultations among ethnic groups in the Netherlands: an epidemiologic study using electronic records from general practices.

Woestenberg PJ, van Oeffelen AA, Stirbu-Wagner I, van Benthem BH, van Bergen JE, van den Broek IV.

BMC Fam Pract. 2015 Jun 18;16:70. doi: 10.1186/s12875-015-0281-2.

16.

Chlamydia screening is not cost-effective at low participation rates: evidence from a repeated register-based implementation study in The Netherlands.

de Wit GA, Over EA, Schmid BV, van Bergen JE, van den Broek IV, van der Sande MA, Welte R, Op de Coul EL, Kretzschmar ME.

Sex Transm Infect. 2015 Sep;91(6):423-9. doi: 10.1136/sextrans-2014-051677. Epub 2015 Mar 10.

PMID:
25759475
17.

Urogenital Chlamydia trachomatis strain types, defined by high-resolution multilocus sequence typing, in relation to ethnicity and urogenital symptoms among a young screening population in Amsterdam, The Netherlands.

Versteeg B, Himschoot M, van den Broek IV, Bom RJ, Speksnijder AG, Schim van der Loeff MF, Bruisten SM.

Sex Transm Infect. 2015 Sep;91(6):415-22. doi: 10.1136/sextrans-2014-051790. Epub 2015 Feb 16.

PMID:
25688105
18.

Genital chlamydia prevalence in Europe and non-European high income countries: systematic review and meta-analysis.

Redmond SM, Alexander-Kisslig K, Woodhall SC, van den Broek IV, van Bergen J, Ward H, Uusküla A, Herrmann B, Andersen B, Götz HM, Sfetcu O, Low N.

PLoS One. 2015 Jan 23;10(1):e0115753. doi: 10.1371/journal.pone.0115753. eCollection 2015. Review.

19.

Chlamydia trachomatis Antibody Testing in Vaginal Mucosal Material versus Blood Samples of Women Attending a Fertility Clinic and an STI Clinic.

van den Broek IV, Land JA, van Bergen JE, Morré SA, van der Sande MA.

Obstet Gynecol Int. 2014;2014:601932. doi: 10.1155/2014/601932. Epub 2014 Mar 13.

20.

Chlamydia trachomatis IgG seroprevalence in the general population of the Netherlands in 1996 and in 2007: differential changes by gender and age.

van Aar F, de Moraes M, Morré SA, van Bergen JE, van der Klis FR, Land JA, van der Sande MA, van den Broek IV.

Sex Transm Infect. 2014 Aug;90(5):434-40. doi: 10.1136/sextrans-2013-051074. Epub 2014 Feb 28.

PMID:
24583966
21.

Consultations for sexually transmitted infections in the general practice in the Netherlands: an opportunity to improve STI/HIV testing.

Trienekens SC, van den Broek IV, Donker GA, van Bergen JE, van der Sande MA.

BMJ Open. 2013 Dec 30;3(12):e003687. doi: 10.1136/bmjopen-2013-003687.

22.

Detection of anorectal and cervicovaginal Chlamydia trachomatis infections following azithromycin treatment: prospective cohort study with multiple time-sequential measures of rRNA, DNA, quantitative load and symptoms.

Dukers-Muijrers NH, Speksnijder AG, Morré SA, Wolffs PF, van der Sande MA, Brink AA, van den Broek IV, Werner MI, Hoebe CJ.

PLoS One. 2013 Nov 20;8(11):e81236. doi: 10.1371/journal.pone.0081236. eCollection 2013.

23.

Use of Chlamydia trachomatis high-resolution typing: an extended case study to distinguish recurrent or persistent infection from new infection.

Götz HM, Bom RJ, Wolfers ME, Fennema J, van den Broek IV, Speksnijder AG, Bruisten SM.

Sex Transm Infect. 2014 Mar;90(2):155-60. doi: 10.1136/sextrans-2013-051218. Epub 2013 Nov 14.

PMID:
24234071
24.

Retesting for genital Chlamydia trachomatis among visitors of a sexually transmitted infections clinic: randomized intervention trial of home- versus clinic-based recall.

Götz HM, Wolfers ME, Luijendijk A, van den Broek IV.

BMC Infect Dis. 2013 May 24;13:239. doi: 10.1186/1471-2334-13-239.

25.

Effects of population based screening for Chlamydia infections in the Netherlands limited by declining participation rates.

Schmid BV, Over EA, van den Broek IV, Op de Coul EL, van Bergen JE, Fennema JS, Götz HM, Hoebe CJ, de Wit GA, van der Sande MA, Kretzschmar ME.

PLoS One. 2013;8(3):e58674. doi: 10.1371/journal.pone.0058674. Epub 2013 Mar 20.

26.

Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation.

van den Broek IV, van Bergen JE, Brouwers EE, Fennema JS, Götz HM, Hoebe CJ, Koekenbier RH, Kretzschmar M, Over EA, Schmid BV, Pars LL, van Ravesteijn SM, van der Sande MA, de Wit GA, Low N, Op de Coul EL.

BMJ. 2012 Jul 5;345:e4316. doi: 10.1136/bmj.e4316.

27.

High yield of reinfections by home-based automatic rescreening of Chlamydia positives in a large-scale register-based screening programme and determinants of repeat infections.

Götz HM, van den Broek IV, Hoebe CJ, Brouwers EE, Pars LL, Fennema JS, Koekenbier RH, van Ravesteijn S, Op de Coul EL, van Bergen J.

Sex Transm Infect. 2013 Feb;89(1):63-9. doi: 10.1136/sextrans-2011-050455. Epub 2012 Jun 23.

PMID:
22728910
28.

Keeping participants on board: increasing uptake by automated respondent reminders in an Internet-based chlamydia screening in the Netherlands.

Dokkum NF, Koekenbier RH, van den Broek IV, van Bergen JE, Brouwers EE, Fennema JS, Götz HM, Hoebe CJ, Pars LL, van Ravesteijn SM, Op de Coul EL.

BMC Public Health. 2012 Mar 9;12:176. doi: 10.1186/1471-2458-12-176.

29.

Who participates in the Dutch Chlamydia screening? A study on demographic and behavioral correlates of participation and positivity.

Op de Coul EL, Götz HM, van Bergen JE, Fennema JS, Hoebe CJ, Koekenbier RH, Pars LL, van Ravesteijn SM, van der Sande MA, van den Broek IV.

Sex Transm Dis. 2012 Feb;39(2):97-103. doi: 10.1097/OLQ.0b013e3182383097.

PMID:
22249297
30.

Systematic selection of screening participants by risk score in a Chlamydia screening programme is feasible and effective.

van den Broek IV, Brouwers EE, Götz HM, van Bergen JE, Op de Coul EL, Fennema JS, Koekenbier RH, Pars LL, van Ravesteijn SM, Hoebe CJ.

Sex Transm Infect. 2012 Apr;88(3):205-11. doi: 10.1136/sextrans-2011-050219. Epub 2012 Jan 3.

PMID:
22215696
31.

Chlamydia infection, pelvic inflammatory disease, ectopic pregnancy and infertility: cross-national study.

Bender N, Herrmann B, Andersen B, Hocking JS, van Bergen J, Morgan J, van den Broek IV, Zwahlen M, Low N.

Sex Transm Infect. 2011 Dec;87(7):601-8. doi: 10.1136/sextrans-2011-050205. Epub 2011 Oct 25.

PMID:
22028428
32.

Comparing two definitions of ethnicity for identifying young persons at risk for chlamydia.

Haasnoot A, Koedijk FD, Op De Coul EL, Götz HM, van der Sande MA, Van Den Broek IV; CSI Group.

Epidemiol Infect. 2012 May;140(5):951-8. doi: 10.1017/S0950268811001336. Epub 2011 Jul 18.

PMID:
21767454
33.

Usefulness of primary care electronic networks to assess the incidence of chlamydia, diagnosed by general practitioners.

Suijkerbuijk AW, van den Broek IV, Brouwer HJ, Vanrolleghem AM, Joosten JH, Verheij RA, van der Sande MA, Kretzschmar ME.

BMC Fam Pract. 2011 Jul 8;12:72. doi: 10.1186/1471-2296-12-72.

34.

Acceptability of the internet-based Chlamydia screening implementation in the Netherlands and insights into nonresponse.

Greenland KE, Op de Coul EL, van Bergen JE, Brouwers EE, Fennema HJ, Götz HM, Hoebe CJ, Koekenbier RH, Pars LL, van Ravesteijn SM, van den Broek IV.

Sex Transm Dis. 2011 Jun;38(6):467-74. doi: 10.1097/OLQ.0b013e318204546e.

PMID:
21217416
35.

Rationale, design, and results of the first screening round of a comprehensive, register-based, Chlamydia screening implementation programme in the Netherlands.

van Bergen JE, Fennema JS, van den Broek IV, Brouwers EE, de Feijter EM, Hoebe CJ, Koekenbier RH, de Coul EL, van Ravesteijn SM, Götz HM.

BMC Infect Dis. 2010 Oct 7;10:293. doi: 10.1186/1471-2334-10-293.

36.

Trends in sexually transmitted infections in the Netherlands, combining surveillance data from general practices and sexually transmitted infection centers.

van den Broek IV, Verheij RA, van Dijk CE, Koedijk FD, van der Sande MA, van Bergen JE.

BMC Fam Pract. 2010 May 20;11:39. doi: 10.1186/1471-2296-11-39.

37.

Evaluation design of a systematic, selective, internet-based, Chlamydia screening implementation in the Netherlands, 2008-2010: implications of first results for the analysis.

van den Broek IV, Hoebe CJ, van Bergen JE, Brouwers EE, de Feijter EM, Fennema JS, Götz HM, Koekenbier RH, van Ravesteijn SM, de Coul EL.

BMC Infect Dis. 2010 Apr 7;10:89. doi: 10.1186/1471-2334-10-89.

38.

[Male urethritis in general practice. STDs more common at a younger age].

Vriend HJ, Donker GA, van Bergen JE, van der Sande MA, van den Broek IV.

Ned Tijdschr Geneeskd. 2009;153:A323. Dutch.

PMID:
19900307
39.

Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria.

Pearce RJ, Pota H, Evehe MS, Bâ el-H, Mombo-Ngoma G, Malisa AL, Ord R, Inojosa W, Matondo A, Diallo DA, Mbacham W, van den Broek IV, Swarthout TD, Getachew A, Dejene S, Grobusch MP, Njie F, Dunyo S, Kweku M, Owusu-Agyei S, Chandramohan D, Bonnet M, Guthmann JP, Clarke S, Barnes KI, Streat E, Katokele ST, Uusiku P, Agboghoroma CO, Elegba OY, Cissé B, A-Elbasit IE, Giha HA, Kachur SP, Lynch C, Rwakimari JB, Chanda P, Hawela M, Sharp B, Naidoo I, Roper C.

PLoS Med. 2009 Apr 14;6(4):e1000055. doi: 10.1371/journal.pmed.1000055. Epub 2009 Apr 14.

40.

Methicillin-resistant Staphylococcus aureus in people living and working in pig farms.

VAN DEN Broek IV, VAN Cleef BA, Haenen A, Broens EM, VAN DER Wolf PJ, VAN DEN Broek MJ, Huijsdens XW, Kluytmans JA, VAN DE Giessen AW, Tiemersma EW.

Epidemiol Infect. 2009 May;137(5):700-8. doi: 10.1017/S0950268808001507. Epub 2008 Oct 24.

PMID:
18947444
42.

Efficacy of chloroquine + sulfadoxine--pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh.

van den Broek IV, Maung UA, Peters A, Liem L, Kamal M, Rahman M, Rahman MR, Bangali AM, Das S, Barends M, Faiz AM.

Trans R Soc Trop Med Hyg. 2005 Oct;99(10):727-35.

PMID:
16095643
43.

Geographical distribution of selected and putatively neutral SNPs in Southeast Asian malaria parasites.

Anderson TJ, Nair S, Sudimack D, Williams JT, Mayxay M, Newton PN, Guthmann JP, Smithuis FM, Tran TH, van den Broek IV, White NJ, Nosten F.

Mol Biol Evol. 2005 Dec;22(12):2362-74. Epub 2005 Aug 10.

PMID:
16093566
44.

Drug resistance in Plasmodium falciparum from the Chittagong Hill Tracts, Bangladesh.

van den Broek IV, van der Wardt S, Talukder L, Chakma S, Brockman A, Nair S, Anderson TC.

Trop Med Int Health. 2004 Jun;9(6):680-7.

45.

Chloroquine, sulfadoxine-pyrimethamine and amodiaquine efficacy for the treatment of uncomplicated Plasmodium falciparum malaria in Upper Nile, south Sudan.

van den Broek IV, Gatkoi T, Lowoko B, Nzila A, Ochong E, Keus K.

Trans R Soc Trop Med Hyg. 2003 Mar-Apr;97(2):229-35.

PMID:
14584383

Supplemental Content

Loading ...
Support Center